|
|
||||||||
The FASEB Journal, Vol 4, 2989-3000, Copyright © 1990 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
MS Simonson and MJ Dunn
Department of Medicine, School of Medicine, Case Western Reserve University, University Hospitals, Cleveland, Ohio 44106.
Endothelins (ET) are a family of regulatory peptides synthesized by selected endothelial and epithelial cells that act in a paracrine fashion on nearby smooth muscle or connective tissue cells. We review the pathways of transmembrane signaling triggered by binding of endothelin peptides to receptors on the plasma membrane. Although our understanding of many components is unclear, endothelin peptides appear to evoke a phosphoinositide-linked signaling system that bears a striking resemblance to signaling pathways activated by other regulatory peptides. Expression of endothelin receptors and specific pathways stimulated by activated receptors are controlled in a cell- and tissue-specific manner, which perhaps explains the diverse biological actions of endothelin in different tissues. Complex negative feedback pathways regulate endothelin-induced signaling at the receptor and second messenger levels. Moreover, by regulating the activity of sequence-specific DNA binding proteins, short-term signals by ET can be extended to long-term effects involving gene expression. Regulation of gene expression by ET could account for complex events such as mitogenesis and vascular and tissue remodeling in disease.
This article has been cited by other articles:
![]() |
G.-W. He, M.-H. Liu, Q. Yang, A. Furnary, and A. P.C. Yim Role of Endothelin-1 Receptor Antagonists in Vasoconstriction Mediated by Endothelin and Other Vasoconstrictors in Human Internal Mammary Artery Ann. Thorac. Surg., November 1, 2007; 84(5): 1522 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hatae, N. Aksentijevich, H. W. Zemkova, K. Kretschmannova, M. Tomic, and S. S. Stojilkovic Cloning and Functional Identification of Novel Endothelin Receptor Type A Isoforms in Pituitary Mol. Endocrinol., May 1, 2007; 21(5): 1192 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.J. Halcox, K. R.A. Nour, G. Zalos, and A. A. Quyyumi Endogenous Endothelin in Human Coronary Vascular Function: Differential Contribution of Endothelin Receptor Types A and B Hypertension, May 1, 2007; 49(5): 1134 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Lee, M.-S. Lin, T.-F. Chou, and N.-C. Chang Effect of simvastatin on left ventricular mass in hypercholesterolemic rabbits Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1352 - H1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation Physiol Rev, October 1, 2004; 84(4): 1155 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sorokin and D. E. Kohan Physiology and pathology of endothelin-1 in renal mesangium Am J Physiol Renal Physiol, October 1, 2003; 285(4): F579 - F589. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Shin, Y. P. Lee, T. S. Lee, H. D. Je, D. S. Kim, and U. D. Sohn The Signal Transduction of Endothelin-1-Induced Circular Smooth Muscle Cell Contraction in Cat Esophagus J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 924 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Asberg, K. Midtvedt, T. Vassbotn, and A. Hartmann Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1465 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bouayad, H. Kajino, N. Waleh, J.-C. Fouron, G. Andelfinger, D. R. Varma, A. Skoll, A. Vazquez, F. Gobeil Jr, R. I. Clyman, et al. Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2342 - H2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. McAllister, K. L. Luther, and P. C. Pfeifer Thyroid status and response to endothelin-1 in rat arterial vessels Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E252 - E258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. H. HONING, M. L. HIJMERING, D. E. BALLARD, Y. P. YANG, R. J. PADLEY, P. J. MORRISON, and T. J. RABELINK Selective ETA Receptor Antagonism with ABT-627 Attenuates All Renal Effects of Endothelin in Humans J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1498 - 1504. [Abstract] [Full Text] |
||||
![]() |
H. C. Hercule and A. O. Oyekan Cytochrome P450 omega /omega -1 Hydroxylase-Derived Eicosanoids Contribute to EndothelinA and EndothelinB Receptor-Mediated Vasoconstriction to Endothelin-1 in the Rat Preglomerular Arteriole J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1153 - 1160. [Abstract] [Full Text] |
||||
![]() |
P. Nambi, H.-L. Wu, D. Ye, A. Gagnon, and N. Elshourbagy Characterization of a Novel Porcine EndothelinB Receptor Splice Variant J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 247 - 253. [Abstract] [Full Text] |
||||
![]() |
A. Kimura, M. Ohmichi, H. Kurachi, H. Ikegami, J. Hayakawa, K. Tasaka, Y. Kanda, Y. Nishio, H. Jikihara, N. Matsuura, et al. Role of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Cascade in Gonadotropin-releasing Hormone-induced Growth Inhibition of a Human Ovarian Cancer Cell Line Cancer Res., October 1, 1999; 59(20): 5133 - 5142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kimura, M. Ohmichi, T. Takeda, H. Kurachi, H. Ikegami, K. Koike, K. Masuhara, J. Hayakawa, T. Kanzaki, M. Kobayashi, et al. Mitogen-Activated Protein Kinase Cascade Is Involved in Endothelin-1-Induced Rat Puerperal Uterine Contraction Endocrinology, February 1, 1999; 140(2): 722 - 731. [Abstract] [Full Text] |
||||
![]() |
R. Shao, W. Yan, and D. C. Rockey Regulation of Endothelin-1 Synthesis by Endothelin-converting Enzyme-1 during Wound Healing J. Biol. Chem., January 29, 1999; 274(5): 3228 - 3234. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. A. Blezer, K. Nicolay, R. Goldschmeding, G. H. Jansen, H. A. Koomans, T. J. Rabelink, and J. A. Joles Early-Onset But Not Late-Onset Endothelin-A–Receptor Blockade Can Modulate Hypertension, Cerebral Edema, and Proteinuria in Stroke-Prone Hypertensive Rats Hypertension, January 1, 1999; 33(1): 137 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Borcsok, H. U. Schairer, U. Sommer, G. K. Wakley, U. Schneider, F. Geiger, F. U. Niethard, R. Ziegler, and C. H. Kasperk Glucocorticoids Regulate the Expression of the Human Osteoblastic Endothelin A Receptor Gene J. Exp. Med., November 2, 1998; 188(9): 1563 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caligiuri, S. Glaser, R. E. Rodgers, J. L. Phinizy, W. Robertson, E. Papa, M. Pinzani, and G. Alpini Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G835 - G846. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hiruma, A. Inoue, A. Shiohama, E. Otsuka, S. Hirose, A. Yamaguchi, and H. Hagiwara Endothelins inhibit the mineralization of osteoblastic MC3T3-E1 cells through the A-type endothelin receptor Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1099 - R1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Leis, D. Zach, E. Huber, and W. Windischhofer Prostaglandin Endoperoxide Synthase-2 Contributes to the Endothelin/Sarafotoxin-Induced Prostaglandin E2 Synthesis in Mouse Osteoblastic Cells (MC3T3-E1): Evidence for a Protein Tyrosine Kinase-Signaling Pathway and Involvement of Protein Kinase C Endocrinology, March 1, 1998; 139(3): 1268 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Oyekan and J. C. McGiff Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R52 - R61. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kanyicska, M. E. Freeman, and S. E. Dryer Endothelin Activates Large-Conductance K+ Channels in Rat Lactotrophs: Reversal by Long-Term Exposure to Dopamine Agonist Endocrinology, August 1, 1997; 138(8): 3141 - 3153. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dunbar Ivy, J. P. Kinsella, and S. H. Abman Endothelin blockade augments pulmonary vasodilation in the ovine fetus J Appl Physiol, December 1, 1996; 81(6): 2481 - 2487. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Elshourbagy, J. E. Adamou, A. W. Gagnon, H.-L. Wu, M. Pullen, and P. Nambi Molecular Characterization of a Novel Human Endothelin Receptor Splice Variant J. Biol. Chem., October 11, 1996; 271(41): 25300 - 25307. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaddoura, J. D. Firth, K. R. Boheler, P. H. Sugden, and P. A. Poole-Wilson Endothelin-1 Is Involved in Norepinephrine-Induced Ventricular Hypertrophy In Vivo : Acute Effects of Bosentan, an Orally Active, Mixed Endothelin ETA and ETB Receptor Antagonist Circulation, June 1, 1996; 93(11): 2068 - 2079. [Abstract] [Full Text] |
||||
![]() |
M. S. Simonson, Y. Wang, and W. H. Herman Nuclear Signaling by Endothelin-1 Requires Src Protein-tyrosine Kinases J. Biol. Chem., January 5, 1996; 271(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Levin Endothelins N. Engl. J. Med., August 10, 1995; 333(6): 356 - 363. [Full Text] [PDF] |
||||
![]() |
N. O. Dulin, J. Niu, D. D. Browning, R. D. Ye, and T. Voyno-Yasenetskaya Cyclic AMP-independent Activation of Protein Kinase A by Vasoactive Peptides J. Biol. Chem., June 8, 2001; 276(24): 20827 - 20830. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.J. Halcox, K. R.A. Nour, G. Zalos, and A. A. Quyyumi Coronary Vasodilation and Improvement in Endothelial Dysfunction With Endothelin ETA Receptor Blockade Circ. Res., November 23, 2001; 89(11): 969 - 976. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |